Industries > Pharma > Global OTC Pharmaceutical Market Forecast 2018-2028

Global OTC Pharmaceutical Market Forecast 2018-2028

Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies

PUBLISHED: 05 April 2018
PAGES: 201
PRODUCT CODE: PHA0298

Clear
WOOCS 2.2.1

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 201-page report you will receive 84 tables and 79 figures– all unavailable elsewhere.

The 201-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global OTC Pharmaceutical Market forecasts from 2018-2028

• This report breaks down the revenue forecast of the Global OTC Pharmaceutical market into these leading segments:
• Analgesics
• Cough, cold and allergy products
• Dermatological products
• Gastrointestinal products
• Eye Care
• Smoking Cessation Aids
• Other products

Each submarket is further divided by region: North America, South America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• North America: the US, Canada, Mexico
• South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
• Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
• Rest of the World: Middle East, Africa, Other Countries

Global OTC Pharmaceutical Market Forecast 2018-2028

Our study provides a SWOT analysis and Porter’s Five Forces analysis of the Global OTC Pharmaceutical market

This report discusses the leading companies in the Global OTC Pharmaceutical market
• Bayer AG
• GlaxoSmithKline (GSK) Consumer Care
• Perrigo Company PLC
• Johnson & Johnson
• Daiichi Sankyo Co., Ltd
• Pfizer Inc.
• Procter & Gamble
• Sanofi S.A
• Reckitt Benckiser Group PLC
• Cipla, Inc.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.

Buy our report today Global OTC Pharmaceutical Market Forecast 2018-2028: Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global OTC Pharmaceutical Market Forecast 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global OTC Pharmaceutical Market Forecast 2018-2028


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories